RxSight (RXST) Cash from Investing Activities (2020 - 2026)

RxSight has reported Cash from Investing Activities for 7 years, with the latest figure at $8.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 57.57% year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 104.75% YoY), and the FY2025 full-year result was $16.9 million, up 117.01% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $8.8 million, up from -$9.6 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $43.8 million in Q2 2022, with the low at -$115.6 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$3.3 million across 5 years, with a median of $4.4 million in 2023.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 2984.82% — and 2024, when it plunged 2731.29%.
• RxSight's Cash from Investing Activities stood at $10.4 million in 2022, then slumped by 56.12% to $4.6 million in 2023, then plunged by 71.09% to $1.3 million in 2024, then tumbled by 828.33% to -$9.6 million in 2025, then surged by 192.03% to $8.8 million in 2026.
• The last three Cash from Investing Activities figures came in at $8.8 million (Q1 2026), -$9.6 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.